Menopause
Obstetrics & Gynaecology · Topic 32
Source: NMC CBME Curriculum 2024 · Volume III · Obstetrics & Gynaecology · Topic 32 · combined PDF page 438
Practice questions
- According to the cited 2025 guideline, which combination defines premature ovarian insufficiency?
- A 36-year-old has spontaneous oligo-amenorrhea for 5 months and an FSH level of 28 IU/L. Which interpretation best fits the cited POI definition?
- Which set contains only causes or risk factors for POI specifically listed in the cited guideline?
- A patient with POI asks why treatment is recommended even though she has no hot flushes. Which response is most consistent with the cited guideline?
- For a patient with POI in whom hormone replacement is indicated, which regimen preference is described in the cited guideline?
- A patient with POI also needs contraception. Which option does the cited guideline say may be considered?
- A young patient with POI asks about future fertility. What does the cited guideline advise regarding fertility-preservation expertise?
- Which statement best describes hormonal changes across perimenopause and menopause according to the cited review?
- Which description most accurately captures genitourinary syndrome of menopause (GSM) in the cited guideline?
- Which cluster consists entirely of symptoms listed in the cited reviews as possible features of GSM?
- A postmenopausal patient reports vaginal dryness and urinary urgency, but examination shows no obvious related physical changes. Which approach best reflects the cited GSM guideline?
- A patient has genitourinary symptoms suggestive of GSM, but another possible cause has not yet been assessed. What is the most appropriate next diagnostic principle?
- Which GSM intervention has the most robust evidence base according to the cited AUA/SUFU/AUGS guideline summary?
- A patient with GSM asks whether she must try each hormonal option in a fixed sequence before selecting one. Which response best reflects the cited guideline?
- When selecting among possible GSM treatments, which decision-making approach is recommended in the cited guideline?
- A review of practical GSM care reports that recent clinical guidelines emphasize which treatment approach as first-line therapy?
- Which statement about the course of GSM is supported by the cited practical review?
- In the cited meta-analysis, how did Black women compare with White women in odds of vasomotor symptom presence?
- Compared with White women, which finding for Asian women was reported in the cited meta-analysis?
- Which pair of factors was associated with both presence and severity of vasomotor symptoms in the cited meta-analysis?
- Which psychosocial factor was associated with increased odds of vasomotor symptom presence in the cited meta-analysis?
- In the cited meta-analysis, which statement about education and income is accurate?
- How should the associations between ethnicity, smoking, obesity, depression, and menopausal symptoms in the cited meta-analysis be interpreted?
- Which statement about menopause hormone therapy in people with epilepsy is best supported by the cited review?
- Which antiseizure medication is specifically mentioned in the cited review as one whose metabolism may be influenced by menopause hormone therapy?
- A patient with epilepsy has distressing menopausal symptoms and asks whether hormone therapy can be considered. Which counseling statement is most consistent with the cited review?
- A postmenopausal patient using semaglutide asks to start menopause hormone therapy solely to increase weight loss. Which response best reflects the cited expert position statement?
- Which incretin-based therapy currently has the largest amount of direct menopause-specific evidence, according to the cited expert position statement?